HPV GSK 580299 Vaccine: 41 Clinical Trials, Page 4 of 5

Hide Studies Not Open or Pending

Immunogenicity of GlaxoSmithKline Biological’s Human Papillomavirus (HPV) Vaccine (580299) Versus Merck’s Gardasil^® in Healthy Females 18-45 Years of Age

Condition(s):Infections, Papillomavirus; Papillomavirus VaccinesLast Updated:January 2, 2020Completed

Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years

Condition(s):Infections, PapillomavirusLast Updated:December 16, 2016Completed

Safety and Immunogenicity of GlaxoSmithKline Biologicals’ HPV Vaccine 580299 (Cervarix) in HIV Infected Females

Condition(s):Infections, PapillomavirusLast Updated:January 3, 2020Completed

Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)

Condition(s):Infections, PapillomavirusLast Updated:May 10, 2017Completed

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

Condition(s):Infections, PapillomavirusLast Updated:June 9, 2020Completed

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals’ (GSK Bio) HPV-16/18 Vaccine

Condition(s):Cervical Intraepithelial Neoplasia; Papillomavirus InfectionLast Updated:September 18, 2012Completed

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects

Condition(s):Infections, PapillomavirusLast Updated:October 30, 2020Completed

Follow-up Study of GSK Biologicals’ Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults

Condition(s):Infections, PapillomavirusLast Updated:November 4, 2016Completed

Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects

Condition(s):Infections, PapillomavirusLast Updated:July 20, 2018Completed

Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial

Condition(s):Human Papillomavirus-Related Cervical CarcinomaLast Updated:October 27, 2020Active, not recruiting

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.